Rapid skin improvement with upadacitinib with or without topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)

被引：0
|
作者：
Simpson, E. L. [1 ]
Warren, R. B. [2 ]
Eichenfield, L. F. [3 ,4 ]
Katoh, N. [5 ]
Hu, X. [6 ]
Zeng, J. [6 ]
Calimlim, B. M. [6 ]
Tenorio, A. R. [6 ]
Teixeira, H. D. [6 ]
De Bruin-Weller, M. [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA
[2] Univ Manchester, Dermatol Ctr, Salford Royal NHS Fdn Trust, Manchester NIHR Biomed Res Ctr, Manchester, Lancs, England
[3] Rady Childrens Hosp, Div Pediat & Adolescent Dermatol, San Diego, CA USA
[4] Univ Calif San Diego, Sch Med, Dept Dermatol & Pediat, San Diego, CA USA
[5] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Dermatol, Kyoto, Japan
[6] AbbVie Inc, N Chicago, IL USA
[7] Univ Med Ctr Utrecht, Dept Dermatol & Allergol, Utrecht, Netherlands
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 185卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
476
引用
收藏
页码：E118 / E119
页数：2
相关论文
共 50 条
  • [1] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Blauvelt, A.
    Ardern-Jones, M. R.
    Bieber, T.
    Hong, C.
    Chu, C. -Y.
    Liu, M.
    Yang, Y.
    Ladizinski, B.
    Teixeira, H. D.
    Calimlim, B. M.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E117 - E118
  • [2] Rapid skin improvement with upadacitinib with or without topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Simpson, Eric L.
    Warren, Richard B.
    Eichenfield, Lawrence F.
    Katoh, Norito
    Hu, Xiaofei
    Zeng, Jiewei
    Calimlim, Brian M.
    Tenorio, Allan R.
    Teixeira, Henrique D.
    De Bruin-Weller, Marjolein
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB167 - AB167
  • [3] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Blauvelt, Andrew
    Ardern-Jones, Michael R.
    Bieber, Thomas
    Hong, Chih-Ho
    Chu, Chia-Yu
    Liu, Meng
    Yang, Yang
    Ladizinski, Barry
    Teixeira, Henrique D.
    Calimlim, Brian M.
    Thyssen, Jacob P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB171 - AB171
  • [4] RAPID SYMPTOM AND SLEEP IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
    Ardern-Jones, Michael R.
    Beck, Lisa A.
    Calimlim, Brian M.
    Zeng, Jiewei
    Chu, Alvina D.
    Prajapati, Vimal H.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 35
  • [5] RAPID QUALITY-OF-LIFE IMPROVEMENT WITH UPADACITINIB WITH OR WITHOUT TOPICAL CORTICOSTEROIDS (TCS) IN MODERATE-TO-SEVERE ATOPIC DERMATITIS: RESULTS FROM 3 PHASE 3 STUDIES (MEASURE UP 1, MEASURE UP 2, AND AD UP)
    Eyerich, Kilian
    Lynde, Charles W.
    Calimlim, Brian M.
    Liu, Meng
    Ladizinski, Barry
    Warren, Richard B.
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 34 - 34
  • [6] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Guttman-Yassky, Emma
    Irvine, A. D.
    Silverberg, J. I.
    Papp, K. A.
    Paller, A. S.
    Waterhouse, B.
    Tenorio, A. R.
    Ladizinski, B.
    Chu, A. D.
    Liu, J.
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
  • [7] Upadacitinib with or without topical corticosteroids improves health-related quality of life in adolescent and adult patients with moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Prajapati, Vimal H.
    Rosmarin, David
    Shumack, Stephen
    Calimlim, Brian M.
    Takemoto, Shunya
    Hu, Xiaofei
    Ladizinski, Barry
    Warren, Richard B.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E81 - E81
  • [8] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Guttman-Yassky, Emma
    Irvine, Alan D.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Waterhouse, Brian
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
  • [9] Achieving incrementally greater skin improvement thresholds with upadacitinib in moderate-to-severe atopic dermatitis: a pooled analysis of two phase III studies (Measure Up 1 and Measure Up 2)
    Reich, K.
    Langley, R. G.
    Calimlim, B. M.
    Teixeira, H. D.
    Zeng, J.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E131 - E132
  • [10] The multidimensional burden of moderate-to-severe atopic dermatitis: a pooled analysis of baseline data from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Silverberg, J. I.
    Thyssen, J. P.
    Costanzo, A.
    Calimlim, B. M.
    Tenorio, A. R.
    Chen, N.
    Gooderham, M. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E126 - E127
12345